Evidence map›Paper›PMID 37864824›Full record

ArticleThe British journal of dermatology2024

Skin Investigation Network of Canada (SkIN Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinoma.

Anabel Bergeron, Carolyn Nessim, Omer Kleiner, Rachael Manion, Jan Dutz, Anie Philip, An-Wen Chan, Skin Investigation Network of Canada Priority Setting Collaborative

Abstract read
In one paragraph

Article in The British journal of dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anabel BergeronUniversity of Ottawa, Ottawa, ON, Canada.ORCID 0000-0002-0424-9597
Carolyn NessimDepartment of Surgery, The Ottawa Hospital, Ottawa, ON, Canada.ORCID 0000-0002-0419-3511
Omer KleinerSkin Investigation Network of Canada (SkIN Canada), Toronto, ON, Canada(the full list of members is available in File S1).
Rachael ManionSkin Investigation Network of Canada (SkIN Canada), Toronto, ON, Canada(the full list of members is available in File S1).
Jan DutzSkin Investigation Network of Canada (SkIN Canada), Toronto, ON, Canada(the full list of members is available in File S1).
Anie PhilipSkin Investigation Network of Canada (SkIN Canada), Toronto, ON, Canada(the full list of members is available in File S1).ORCID 0000-0002-2533-1071
An-Wen ChanSkin Investigation Network of Canada (SkIN Canada), Toronto, ON, Canada(the full list of members is available in File S1).
Skin Investigation Network of Canada Priority Setting Collaborative

Funding

CIHR
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Merkel CellSkin NeoplasmsCanadaHumansSkinSkin Care

Identifiers

PMID37864824
PMCPMC10805522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.